
Levomenthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml)
Active composition
+3 more active ingredients
Terbutaline stimulates beta-2 adrenergic receptors, causing relaxation of bronchial smooth muscle and dilation of airways.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Guaifenesin reduces mucus viscosity by increasing the hydration of secretions in the respiratory tract, facilitating easier expectoration.
Medical applications
Instaryl-P Syrup is a multi-ingredient formulation designed to provide symptomatic relief in respiratory conditions characterized by bronchospasm, excessive mucus production, and cough. Each 5 ml of syrup contains Terbutaline 1.25 mg, a selective beta-2 adrenergic agonist that acts as a bronchodilator, facilitating the relaxation of bronchial smooth muscles and improving airflow in obstructive airway diseases such as asthma and chronic bronchitis. Ambroxol 15 mg serves as a mucolytic agent, promoting the breakdown and clearance of viscous mucus, thereby enhancing expectoration. Guaifenesin 50 mg acts as an expectorant, increasing respiratory tract fluid secretion to help loosen phlegm and ease productive cough. Levomenthol 2.5 mg provides a soothing effect on the respiratory mucosa, offering mild local anesthetic and cooling properties that alleviate throat irritation and cough reflex sensitivity. Instaryl-P Syrup is indicated for the management of acute and chronic respiratory disorders involving bronchospasm and mucus hypersecretion. It should be used under medical supervision, with caution in patients with cardiovascular disorders, hyperthyroidism, or hypersensitivity to any component. The syrup is intended for oral administration, with dosage adjusted according to patient age and clinical response.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Instaryl-P Syrup during pregnancy is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Instaryl-P Syrup in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Instaryl-P Syrup alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Instaryl-P Syrup in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Instaryl-P Syrup

Terbutaline (1.25mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Levomenthol (2.5mg/5ml)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+3 more active ingredients
Terbutaline stimulates beta-2 adrenergic receptors, causing relaxation of bronchial smooth muscle and dilation of airways.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Guaifenesin reduces mucus viscosity by increasing the hydration of secretions in the respiratory tract, facilitating easier expectoration.
Medical applications
Instaryl-P Syrup is a multi-ingredient formulation designed to provide symptomatic relief in respiratory conditions characterized by bronchospasm, excessive mucus production, and cough. Each 5 ml of syrup contains Terbutaline 1.25 mg, a selective beta-2 adrenergic agonist that acts as a bronchodilator, facilitating the relaxation of bronchial smooth muscles and improving airflow in obstructive airway diseases such as asthma and chronic bronchitis. Ambroxol 15 mg serves as a mucolytic agent, promoting the breakdown and clearance of viscous mucus, thereby enhancing expectoration. Guaifenesin 50 mg acts as an expectorant, increasing respiratory tract fluid secretion to help loosen phlegm and ease productive cough. Levomenthol 2.5 mg provides a soothing effect on the respiratory mucosa, offering mild local anesthetic and cooling properties that alleviate throat irritation and cough reflex sensitivity. Instaryl-P Syrup is indicated for the management of acute and chronic respiratory disorders involving bronchospasm and mucus hypersecretion. It should be used under medical supervision, with caution in patients with cardiovascular disorders, hyperthyroidism, or hypersensitivity to any component. The syrup is intended for oral administration, with dosage adjusted according to patient age and clinical response.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Instaryl-P Syrup during pregnancy is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Instaryl-P Syrup in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Instaryl-P Syrup alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Instaryl-P Syrup in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Instaryl-P Syrup















